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Summary
Diffuse sclerosing variant of papillary thyroid carcinoma (DSPTC) is a rare subtype of papillary thyroid carcinoma with a high incidence of lymph node metastasis. One of its characteristic histological features is the presence of dense lymphocyte infiltrates; however, how these lymphocytes are recruited in this pathological setting remains unclear. Here, we analyzed 17 DSPTC cases immunohistologically for cell adhesion molecules expressed on endothelial cells.
We found that venules morphologically similar to high endothelial venules (HEVs) in secondary lymphoid organs were induced in lymphoid aggregates in DSPTC, and such HEV-like vessels 
INTRODUCTION
Papillary carcinoma is the most common type of thyroid carcinoma and represents 80-90% of all primary thyroid malignancies. 1 Several morphological variants of papillary thyroid carcinoma (PTC) are well-recognized, and among them, diffuse sclerosing variant of PTC (DSPTC), which predominantly affects young women, is a relatively rare variant with a high incidence of cervical lymph node metastasis. [2] [3] [4] [5] DSPTC is characterized histologically by scattered islands of papillary carcinoma nests, with occasional squamous metaplasia and psammoma body formation, in cleft-like dilated lymphatic vessels. These regions also exhibit dense stromal fibrosis, and marked lymphocytic infiltrates with occasional germinal center formation reminiscent of
Hashimoto"s thyroiditis. 26 Here we show that HEV-like vessels are induced in dense lymphocyte infiltrates formed in DSPTC. We observed that lymphocytes, primarily CD8 + cytotoxic T cells, attach to the luminal surface of these vessels, suggesting that a subset of lymphocytes constituting DSPTC lymphoid stroma is recruited via these vessels. We also found that sLeX-type glycans, which function as E-selectin ligands, are expressed on DSPTC carcinoma cells, raising the possibility that sLeX-type glycans expressed on tumor cells might function in cancer metastasis. 
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MATERIALS AND METHODS
Tissue samples
Immunohistochemistry and immunofluorescence
Conventional immunohistochemistry for MECA-79, HECA-452 and S1 was conducted as described. 30 Double immunofluorescence for MECA-79 and either ICAM-1, VCAM-1 or MAdCAM-1 was performed as described. 22 Triple immunohistochemistry was carried out 6 essentially as described. 
Quantification of lymphocyte subsets attached to HEV-like vessels
For each lymphocyte subset, we determined the number of cells attached to the luminal surface of 50 randomly selected MECA-79 + HEV-like vessels in specimens of each of the 17 DSPTC cases.
In total, 850 MECA-79 + HEV-like vessels were evaluated, and the mean number of attached cells per vessel was calculated as described. 21 The number of cells in each lymphocyte subset in
Hashimoto"s thyroiditis specimens was similarly determined.
E-selectin•IgM chimera in situ binding assay
E-selectin•IgM chimeras were obtained from the culture medium of COS-7 cells transiently transfected with pcDNA1.1-E-selectin•IgM. 31 An E-selectin•IgM chimera in situ binding assay was carried out as described.
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Statistical analysis
Data are expressed as means ± standard deviation (SD). Differences between groups were statistically analyzed by the two-tailed paired t-test using GraphPad Prism 5 software (GraphPad
RESULTS
Induction of HEV-like vessels in DSPTC lymphocyte aggregates
The cohort of DSPTC cases examined for this study (n = 17) showed strong female predominance (female: male ratio = 16:1), and patient ages at the time of operation ranged from 13 to 53 years, with a median of 29 years. These observations are consistent with reports that DSPTC occurs mainly in young women.
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Additionally, all 17 DSPTC cases exhibited lymphatic invasion and consequent lymph node metastasis, while vascular invasion was not evident by microscopic examination and only two cases showed distant metastasis to the lung (Table 1) . Histologically, all cases examined showed characteristics of DSPTC. As shown in Fig. 1 , scattered islands of papillary carcinoma nests, with or without psammoma bodies and squamous metaplasia, were found within cleft-like dilated lymphatic vessels. Those vessels were surrounded by prominent fibrous stroma with patchy lymphocyte aggregates accompanied by germinal centers. Within aggregates, venules morphologically similar to HEVs in secondary lymphoid organs were frequently observed in all cases examined (Fig. 2, upper panels) . Similar vessels were also observed within lymphoid aggregates in Hashimoto"s thyroiditis (Fig. 2 , middle panels), as previously reported, 6 but were scarcely detectable in WLPTC lymphoid stroma (Fig. 2, lower panels).
Expression of 6-sulfo sLeX glycans on DSPTC HEV-like vessels
We then performed immunohistochemical analysis of glycans expressed on HEV-like vessels seen in DSPTC, along with those seen in Hashimoto"s thyroiditis and WLPTC. As shown in Fig.   2 (upper panels), the luminal surface of DSPTC HEV-like vessels stained positive for both MECA-79 and S1, and approximately half of these vessels were also HECA-452-positive.
HEV-like vessels induced in Hashimoto"s thyroiditis showed similar immunohistochemical profiles (Fig. 2, middle panels) . Interestingly, however, only a few, fine MECA-79-positive vessels were observed in WLPTC lymphoid stroma, and those were HECA-452-and S1-negative (Fig. 2, lower panels) . Considering the carbohydrate epitopes recognized by these antibodies (Fig. 3) , 32 these results strongly suggest that HEV-like vessels induced in DSPTC and
Hashimoto"s thyroiditis express 6-sulfo sLeX glycans and thus may function in the initial step of lymphocyte recruitment, namely, L-selectin-mediated tethering and rolling of lymphocytes along endothelium. On the other hand, fine MECA-79 + vessels seen in WLPTC likely express non-sialylated, non-fucosylated incomplete L-selectin ligand carbohydrates, such as 6-sulfo LacNAc attached to extended core 1 O-glycans.
Expression of ICAM-1 on HEV-like vessels and on DSPTC carcinoma cells
To determine which cell adhesion molecule of the immunoglobulin superfamily is expressed on vessels that express 6-sulfo sLeX glycans, we conducted double immunofluorescence staining for 
Expression of sLeX-type glycans on DSPTC carcinoma cells
In addition to their expression on HEV-like vessels, we found that HECA-452 + sLeX-type glycans are expressed on most DSPTC carcinoma cells (Fig. 9, upper panels) . Interestingly, a fraction of those HECA-452 + carcinoma cells was also positive for MECA-79 (see also Fig. 7) and/or S1, strongly suggesting that sLeX-type glycans expressed on DSPTC carcinoma cells include both non-sulfated and 6-sulfo sLeX glycans. HECA-452 + sLeX-type glycans were also expressed on WLPTC carcinoma cells; however, expression of MECA-79 and/or S1 glycoepitopes was hardly detectable in any case examined (Fig. 9 , lower panels; see also Fig. 2 , lower panels). Conversely, non-neoplastic follicular epithelial cells, including those seen in
Hashimoto"s thyroiditis, completely lacked these glycans (Fig. 9 , middle panels). To determine whether sLeX-type glycans expressed on DSPTC carcinoma cells function as E-selectin ligands,
we conducted an E-selectin•IgM chimera in situ binding assay using DSPTC tissue sections.
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E-selectin•IgM chimeras bound to carcinoma cells (Fig. 10) 
DISCUSSION
In the present study, we demonstrate that HEV-like vessels that express 6-sulfo sLeX glycans and ICAM-1 are induced in lymphocyte aggregates formed not only in Hashimoto"s thyroiditis but also in DSPTC. Moreover, we show that T cells, particularly CD8 + cytotoxic T cells, become preferentially attached to the luminal surface of these vessels. Overall, these findings strongly suggest that HEV-like vessels play at least a partial role in recruitment of CD8 + cytotoxic T cells to lymphocyte aggregates formed in DSPTC.
In our analysis, we employed three different clones of anti-carbohydrate monoclonal antibodies, namely, MECA-79, HECA-452 and S1, whose carbohydrate epitopes overlap with 6-sulfo sLeX glycans, an L-selectin recognition determinant (see Fig. 3 ).
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As noted, HEV-like vessels induced in DSPTC expressed MECA-79 and S1 epitopes; however, approximately one half of those MECA-79/S1-positive vessels lacked HECA-452
immunoreactivity. This finding is in line with our previous studies of chronic Helicobacter pylori gastritis 15, 16 and ulcerative colitis, 18 both of which demonstrated that approximately half of HEV-like vessels were HECA-452-negative. Overall, these observations suggest that 1,3-fucosylation of GlcNAc residues in the sLeX moiety, which is critical for recognition by HECA-452, does not always occur in HEV-like vessels induced in these pathological settings. It is possible that fucosylation, which is elaborated by 1,3-fucosyltransferase 4 and/or 7, 34, 35 modulates the number of lymphocytes recruited through HEV-like vessels.
Interestingly, unlike DSPTC and Hashimoto"s thyroiditis, only a small number of fine MECA-79 + vessels were observed in WLPTC lymphoid stroma, and these lacked S1 or HECA-452 immunoreactivity, strongly suggesting that these vessels express incomplete L-selectin ligands, most likely 6-sulfo LacNAc attached to extended core 1 O-glycans. Moreover, these vessels did not exhibit detectable levels of any immunoglobulin superfamily cell adhesion molecule tested.
These findings collectively suggest that i) mechanisms underlying lymphocyte recruitment in DSPTC are similar to those in Hashimoto"s thyroiditis, and ii) mechanisms underlying lymphocyte recruitment in WLPTC differ and are unique. The same mechanism might contribute in part to the highly metastatic property of DSPTC.
Molecular mechanisms that underlie induction of HEV-like vessels in DSPTC remain
to be elucidated. Chou et al. reported that ALK translocations frequently serve as driver mutations in DSPTC. 39 They also found that 36% of PTC samples exhibiting ALK translocations showed histological evidence of Hashimoto"s thyroiditis. 39 These observations collectively suggest a link between ALK translocations and induction of HEV-like vessels, although further investigations are required for confirmation. BRAF mutations are considered to be driver mutations in roughly 50% of PTC cases. 40 Because the latter are detected not only in WLPTC but in other PTC variants without lymphoid aggregates, 41 it is reasonable to assume that BRAF mutations are not directly responsible for formation of HEV-like vessels.
As noted, CD8 + cytotoxic T cells were the dominant lymphocyte subset attached to the luminal surface of DSPTC HEV-like vessels. While we observed no significant difference in the number of attached B and T cells in our small cohort of Hashimoto"s thyroiditis samples, previous studies reported that B cells attach preferentially to HEV-like vessels in Hashimoto"s thyroiditis. 6 Such differential lymphocyte binding capacities of HEV-like vessels in different pathological settings may be orchestrated by different chemokines acting on these vessels. It is tempting to speculate that, in the case of DSPTC, CCL19 and/or CCL21 facilitate adhesion of T cells to HEV-like vessels through interaction with the CCR7 chemokine receptor expressed on T cells, 42, 43 while CXCL13, which binds to CXCR5 on B cells, may promote preferential adhesion of B cells to HEV-like vessels in Hashimoto"s thyroiditis. 44 It is also possible that vascular adhesion protein 1 (VAP-1), which mediates L-selectin-independent selective binding of CD8 + T cells to endothelial cells, 45 functions in preferential adhesion of CD8 + T cells in DSPTC.
In the present study, we also demonstrate that HECA-452 + sLeX-type glycans are expressed not only on HEV-like vessels but also on DSPTC carcinoma cells and that, in binding assays these carcinoma cells become decorated with E-selectin•IgM chimeras in a calcium-dependent fashion. These sLeX-type glycans include both non-sulfated and 6-sulfo sLeX, and both are physiologically expressed on HEVs and HEV-like vessels.
11 Aberrant expression of 6-sulfo sLeX glycans has been reported in ovarian 46 and gastric 47 carcinomas.
Recently, we also reported that 6-sulfo sLeX glycans are expressed in a fraction of bladder urothelial carcinoma cases and showed that carcinoma cells expressing these glycans were decorated with E-selectin•IgM chimeras calcium-dependently in binding assays. 48 Taken together, these findings suggest that sLeX-type glycans expressed on DSPTC carcinoma cells may function in adhesion between carcinoma cells and E-selectin-expressing lymphatic endothelial cells, 49 an interaction that might contribute in part to significant lymphogenous spreading and subsequent lymph node metastasis that marks DSPTC.
Tumor cell recruitment from the primary site into lymphatic vessels, or lymphatic intravasation, is also prerequisite for development of lymph node metastasis, and several factors, including transforming growth factor  (TGF-), 50 receptor tyrosine kinases 51 and proteases 52, 53 , reportedly function in this process. 54 Among these, it is generally accepted that proteases such as urokinase-type plasminogen activator 52 and matrix metalloproteinases 53 allow tumor cells to invade and pass through the basement membrane to enter the lymphatic vessels. Note that most WLPTC carcinoma cells express ICAM-1 (red in top panels). Bar = 50 m. 
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Data are presented as means ± SD. ***, p < 0.001. 
